ArticleFrontiers in public health2025
A systematic analysis of China's noncommunicable disease policies: policy themes, policy instruments, and policy effectiveness from 2009 to 2025.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Structural imbalance in youth weight management policies in China: a three-dimensional analysis of school responsibility and collaborative support.Frontiers in public health · 2026Article
- Policy text analysis on inheritance and innovation of Mongolian medicine culture in China.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Noncommunicable diseases (NCDs) have become a leading threat to life and health. China is facing a more severe challenge from NCDs than ever before, which not only places enormous pressure on the public health system but also significantly hinders economic development and the achievement of sustainable development goals. Objective: Scientifically sound policies can provide a supportive environment for the prevention and control of NCDs. Therefore, this study aims to identify the strengths and weaknesses of current policies through a multidimensional analysis of policy texts, and to propose corresponding policy recommendations. The goal is to enhance the government's capacity and effectiveness in NCD governance, improve the health level of the entire society, and provide policy insights for China and other countries suffering from NCD burdens. Methods: This study adopts the Latent Dirichlet Allocation (LDA) topic model, content analysis method, and the Policy Modeling Consistency (PMC) model to conduct a multidimensional evaluation of 50 NCD-related policy documents issued by the Chinese government from 2009 to 2025, focusing on three dimensions: policy themes, policy instruments, and policy effectiveness. Results: (1) LDA analysis identified six key policy themes: primary healthcare, health promotion, health equity, healthcare reform and regulation, NCD prevention and control, and public health governance. (2) There was a clear structural imbalance in the use of the three types of policy instruments: supply-type (49.1%), environment-type (36.4%), and demand-type (14.4%). (3) The PMC model was applied to 9 representative policies. Among these, 4 were rated "excellent" and 5 "acceptable," with an average PMC score of 6.19, indicating moderate internal consistency and scientific design, yet with considerable variance in quality across policies. Conclusion: China's NCD policy framework shows generally sound structure and intent. However, imbalances in tool application, limited demand-side engagement, and insufficient cross-sectoral coordination remain challenges. Enhancing interdisciplinary integration, strengthening incentives, and promoting stakeholder collaboration are essential for optimizing NCD governance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.